Skip to content

Worldwide Delirium 1-Day Point Prevalence Study 2023

Worldwide Delirium 1-Day Point Prevalence Study 2023 - WDAD 2023

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00030002
Enrollment
1000
Registered
2022-08-29
Start date
2023-03-15
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F00-F09

Interventions

Group 1: All patients in the ward/unit are observed on the prevalence day at 8:00 a.m. and 8:00 p.m.: It will be reported which type of delirium assessment is used. It will be reported: How many patie

Sponsors

Universitätsklinikum Schleswig-Holstein, Pflegeforschung, Campus Kiel
Lead Sponsor

Eligibility

Sex/Gender
All
Age
0 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients, who are assessable for delirium

Exclusion criteria

Exclusion criteria: Patients who are not assessable for delirium (comatose, sedated, disturbances of consciousness, away for procedures, aphasic, different language, or else)

Design outcomes

Primary

MeasureTime frame
Percentage of delirious patients of all present patients, assessed by a valid delirium assessment tool, in the morning at 8.00 a.m. and in the evening at 8.00 p.m.

Secondary

MeasureTime frame
Delirium specific processess, structures, and barriers on wards/units

Countries

Australia, Brazil, Germany, India, Japan, United Kingdom, United States

Contacts

Public ContactKeibun;Rebecca Liu;von Haken

Critical Care Research Group, Faculty of Medicine, The Prince Charles Hospital, University of Queensland;Universitätsmedizin Mannheim

keiliu0406@gmail.com;rebeca.vonhaken@umm.de0061437606107;+49 621 383-4791

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 6, 2026